A Randomized, Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Investigate the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig (SAR443765) in Adult Participants With High-risk Asthma Who Are Not Currently Eligible for Biologic Treatment
A Randomized, Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Investigate the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig (SAR443765) in Adult Participants With High-risk Asthma Who Are Not Currently Eligible for Biologic Treatment
This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.
The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with subcutaneous (SC) lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, who are not currently eligible for biologic treatments.
Study details include:
Inclusion Criteria:
Exclusion Criteria:
Participants are excluded from the study if any of the following criteria apply:
NOTE: The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical study.
Saraland, Alabama 36571, United States
North Hollywood, California 91606, United States
San Mateo, California 94403, United States
Washington D.C., District of Columbia 20060, United States
Cutler Bay, Florida 33157, United States
DeBary, Florida 32713, United States
Pembroke Pines, Florida 33025, United States
Champaign, Illinois 61820, United States
Rockville, Maryland 20854, United States
Silver Spring, Maryland 20901, United States
Ann Arbor, Michigan 48109, United States
Rochester, Minnesota 55905, United States
New York, New York 10011, United States
Statesville, North Carolina 28625, United States
DuBois, Pennsylvania 15801, United States
Philadelphia, Pennsylvania 19107, United States
Greenville, South Carolina 29607, United States
Boerne, Texas 78006, United States
San Antonio, Texas 78249, United States
Curitiba, Paraná 80060-900, Brazil
Porto Alegre, Rio Grande do Sul 90610-000, Brazil
Porto Alegre, Rio Grande do Sul 91010-006, Brazil
Torette, Ancona 60020, Italy
Shinagawa, Tokyo 142-8666, Japan
Ostrowiec Świętokrzyski, Świętokrzyskie Voivodeship 27-400, Poland